Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected to Post Earnings of -$1.30 Per Share

Wall Street analysts forecast that Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) will report ($1.30) earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have made estimates for Mirum Pharmaceuticals’ earnings. The lowest EPS estimate is ($1.47) and the highest is ($1.03). Mirum Pharmaceuticals posted earnings of ($1.68) per share in the […]

Related Keywords

Niall Odonnel ,Raymond James ,Mirum Pharmaceuticals ,Zacks Investment Research ,Mirum Pharmaceuticals Get Rating ,Nasdaq ,Bioimpact Capital ,Capital Management ,Silvercrest Asset Management Group ,Mirum Pharmaceuticals Inc ,Wall Street ,Get Rating ,Mirum Pharmaceutical ,Impact Capital ,Asset Management Group ,Niallo Donnel ,Michael Grey ,Christopher Peetz ,Foster City ,Nasdaq Mirm ,Smirm ,Medical ,Ratings ,Consensus ,